<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03072108</url>
  </required_header>
  <id_info>
    <org_study_id>15.16.CLI</org_study_id>
    <nct_id>NCT03072108</nct_id>
  </id_info>
  <brief_title>Dietary Supplement for Joint: the OLE Study</brief_title>
  <official_title>Effect of Oleuropein-based Dietary Supplement (Bonolive™) Versus Placebo on Knee Joint Functionality and Cartilage Catabolism in Ageing Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Artialis</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical study evaluates if the oral administration of Bonolive can contribute to the
      improvement of functionnality in healthy elderly people with knee discomfort.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 24, 2016</start_date>
  <completion_date type="Anticipated">September 10, 2018</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the effect of investigational product after 6 months of supplementation</measure>
    <time_frame>From Baseline to 6 months of product administration and compared to Placebo</time_frame>
    <description>KOOS (Knee injury and Osteoarthritis Outcome Score)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the effect of investigational product after 6 months of supplementation</measure>
    <time_frame>From Baseline to 6 months of product administration and compared to Placebo</time_frame>
    <description>Biomarker of cartilage breakdown (Coll2.1-NO2)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the effect of investigational product</measure>
    <time_frame>From Baseline to 6 months of product administration and compared to Placebo</time_frame>
    <description>Knee pain VAS score at rest and at walking</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the effect of investigational product</measure>
    <time_frame>From Baseline to 6 months of product administration and compared to Placebo</time_frame>
    <description>OARSI core set of performance-based tests</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Evaluation of food habits and frequency using patient-reported questionnaire</measure>
    <time_frame>From the date of inclusion until end of study, on a monthly basis, up to 6 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">138</enrollment>
  <condition>Knee Discomfort</condition>
  <condition>Knee Pain</condition>
  <arm_group>
    <arm_group_label>Bonolive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Bonolive</intervention_name>
    <description>2 caps per day of Bonolive</description>
    <arm_group_label>Bonolive</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>2 caps per day of Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female ≥ 55 years of age

          -  BMI between 18.5 and 29.9 kg/m2 (normo and overweight)

          -  Moderate knee pain (the most painful knee is considered)

          -  Able to follow the instructions of the study

          -  Able to perform physical tests

          -  Having signed an informed consent

        Exclusion Criteria:

        Related to knee

          -  Recent trauma (&lt; 1 month) of the knee responsible of the symptomatic knee

          -  Subject with knee/joint surgery/replacement and ACL (Cross Ligament) injury in the
             target knee

          -  Concurrent articular disease interfering with the evaluation of pain such as articular
             dysplasia, aseptic osteonecrosis, acromegaly, Paget's disease, hemophilia,
             hemochromatosis, chondromatosis, villonodular synovitis of the knee, seronegative
             spondyloarthropathy, rheumatoid arthritis, gouty arthritis , infectious arthritis,
             radiculalgia in the lower limbs, arteritis

          -  Prosthesis in the target knee

          -  Diagnosed arthrosis eligible to knee/joint surgery/replacement

        Related to treatments

          -  Analgesics to manage knee pain 24h before inclusion visit

          -  Corticosteroids injection in the target knee in the month preceding inclusion

          -  Hyaluronan injection in the target knee in the last 6 months

          -  Oral corticotherapy ≥ 5mg/day in the last 3 months

          -  Symptomatic slow-acting drugs (SYSADs) treatment (Chondroitin, diacerein, glucosamine,
             soy and avocado unsaponifiables) in the last 3 months

          -  Other dietary supplements used for articular disorders in the last 3 months

          -  An anticipated need for the duration of the trial of corticosteroids or hyaluronan
             injection, oral corticotherapy, arthroscopy, analgesics other than listed as rescue
             treatments, which are forbidden during the trial

          -  Arthroscopy in the last 6 months

          -  Allergy or contra-indication to Oleuropein, to maltodextrin or any ingredient present
             in the product, or intolerance to rescue treatment (Paracetamol and NSAIDs)

          -  Treatments based on strontium ranelate, bisphosphonates, selective estrogen-receptor
             modulator (SERM) and parathormone (PTH) during the year before inclusion

        Related to associated diseases

          -  Severe and uncontrolled diseases (liver or renal failure, lung/heart severe disease,
             Parkinson, progressive malignant neoplasia or in remission for less than 5 years, HIV,
             etc.)

          -  Lower or upper extremity surgery or fracture in the last 3 months

          -  Anticipated need for any surgical or other invasive procedure during the trial
             including prosthesis in the target knee

          -  Swallowing disorder

        Related to patients

          -  Close collaborators to the investigational team, the study coordinator (Artialis) or
             to the Sponsor (Nestlé)

          -  Currently participating or having participated in another therapeutic clinical trial
             in the three previous months

          -  Having made a blood donation in the past month

          -  Under guardianship or judicial protection

          -  Pregnancy, breastfeeding, planned conception

          -  Premenopausal women or women without tubal ligation or contraception.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anne-Sophie BALLESTER</last_name>
    <phone>+41 21 785 8733</phone>
    <email>Anne-Sophie.Ballester@rdls.nestle.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Madleen Saboundjian</last_name>
    <phone>+41 21 785 9551</phone>
    <email>Madleen.Saboundjian@rdls.nestle.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Liège</name>
      <address>
        <city>Liege</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves Henrotin, Pr</last_name>
      <phone>+32 4 242 77 97</phone>
      <email>yves.henrotin@artialis.com</email>
    </contact>
    <investigator>
      <last_name>Michel Malaise, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2017</study_first_submitted>
  <study_first_submitted_qc>March 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2017</study_first_posted>
  <last_update_submitted>March 1, 2017</last_update_submitted>
  <last_update_submitted_qc>March 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

